Australia markets open in 7 hours 41 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.38-0.20 (-1.47%)
As of 10:19AM EST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2021
30/09/2020
30/09/2019
30/09/2018
Cash flows from operating activities
Net income
-37,909
-37,909
-26,280
-26,295
-17,453
Depreciation & amortisation
-
-
-
-
0
Stock-based compensation
8,231
8,231
4,877
6,431
5,517
Change in working capital
-706.443
-706.443
116.518
1,302
-646.001
Accounts payable
750.727
750.727
465.722
683.797
-
Other working capital
-30,384
-30,384
-21,287
-18,527
-12,582
Other non-cash items
-
-
-
35.375
-
Net cash provided by operating activities
-30,384
-30,384
-21,287
-18,527
-12,582
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
153,219
153,219
28,754
17,832
8,174
Other financing activities
-5,551
-5,551
-403.764
-50
-101.133
Net cash used provided by (used for) financing activities
153,242
153,242
28,350
17,782
8,073
Net change in cash
122,859
122,859
7,063
-745.008
-4,510
Cash at beginning of period
29,249
29,249
22,186
22,931
27,440
Cash at end of period
152,108
152,108
29,249
22,186
22,931
Free cash flow
Operating cash flow
-30,384
-30,384
-21,287
-18,527
-12,582
Free cash flow
-30,384
-30,384
-21,287
-18,527
-12,582